Apple called out by economist over failing to pay taxes
Stiglitz says Apple needs to pay its fair share
Putin's Russian banker: US sanctions on me 'are very much unjustified'
"I didn't do any wrongdoing," Russian President Vladimir Putin's banker Andrey Kostin maintained as he made the case for why the sanctions are unfair.
Stocks claw back as WHO says coronavirus outbreak not 'global emergency'
Stocks turned around in volatile session.
Coronavirus: Gauging impact on US economy
The Wuhan coronavirus's mortality rate of less than 3 percent compares with almost 15 percent for the SARS epidemic in 2003.
Asian stock markets swoon as China battles coronavirus
China and other nations have ramped up screenings at airports.
American Airlines profit tops Wall Street targets
American canceled about 10,000 flights because of the grounding of the 737 Max.
JetBlue curbs costs to enable low airfares for next decade
JetBlue Airways Corp said it is delivering on a cost-cutting drive designed to enable budget-friendly airfares over the next decade.
Southwest Airlines profit plunges as 737 Max grounding bites
The Dallas-based airline earned $514 million, or 98 cents per share, as sales rose 0.4 percent year-over-year to $5.7 billion.
US stocks trade cautiously on deadly virus concerns
Stocks finished mixed in the last session
Ford expects $2.2B pre-tax hit due to pension plans
It will result in a hit to Ford's net income by about $1.7 billion in the quarter
Amazon asks court to pause Microsoft's work on Pentagon's JEDI contract
The contract is intended to give the military better access to data and technology from remote locations
Boeing weighs on Dow
All three of the major averages remain within striking distance of record highs.
Boeing 737 Max production freeze to end in months
CEO David Calhoun doesn’t expect Boeing to suspend or cut its dividend of $2.06 a share.
United gives up on flying 737 Max during summer travel season
United reported a fourth-quarter profit of $641 million, or $2.53 a share, as revenue rose nearly 4 percent to $10.9 billion.
Johnson & Johnson misses revenue estimates as blockbuster drugs disappoint
Johnson & Johnson narrowly missed quarterly revenue estimates on Wednesday as sales of its blockbuster psoriasis medicine Stelara and cancer drug Imbruvica fell short of expectations.
Activist hedge fund Elliott sells stakes in Hyundai companies: Report
The hedge fund's campaign demanding $6 billion in dividends and board seats was thwarted in March.
Costco’s sea cucumbers sign of global growth opportunity
The membership warehouse retailer is getting its groove back.
Stocks rebound following China virus driven selloff
The S&P 500 three-day winning streak was snapped on Tuesday
Trump to break bread with Apple's Cook and other CEOs
Trump also attended a dinner with executives from multinational corporations
Toyota recalls 2.9M vehicles; air bags may not inflate
Owners will be notified by mid-March.



















